We are monitoring the impact of COVID-19 & Recession alarm on MEA Ophthalmology Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Ophthalmology Therapeutics Market Research Report – Segmented By Indication, End User and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 1048
Pages: 145

MEA Ophthalmology Therapeutics Market Size (2022 to 2027)

The Ophthalmology Therapeutics Market size in the Middle East and Africa was worth USD 3.04 billion in 2022. It is further estimated to grow at a CAGR of 8.1% and worth USD 4.48 billion by 2027.

Ophthalmology is the science associated with the treatment of eye defects and diseases. Recent advancements in genetics and stem cell biology are progressively boosting the potential for ophthalmology therapeutics.

The growing prevalence of vision impairment drives the Middle East and Africa market for Ophthalmology Therapeutics. Advancements in the field of medicine is also a key factor driving the growth of the market. The increasing geriatric population around the region and an increase in the disposable income of the people are some of the other driving factors for the Ophthalmology Therapeutics Market.

However, limited awareness about the diseases associated with ophthalmology is the key restraint for the market's growth. Uncertain reimbursement policies and stringent regulatory frameworks are some of the other factors restraining the market's growth.

This research report on the MEA Ophthalmology Therapeutics Market has been segmented and sub-segmented into the following categories:

By Indication: 

  • Glaucoma
  • Dry Eye Syndrome
  • Diabetic Retinopathy
  • Retinal Vein Occlusion
  • Age-related Macular Degeneration
  • Macular Edema
  • Allergic Conjunctivitis

By End User: 

  • Hospitals
  • Eye Clinics
  • Diagnostic Centres
  • Patients

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Based on end-user, the Hospital segment accounts for the largest share of the market with a percentage share of approximately XX%. At the same time, Diagnostics Centres are the fastest-growing segment with a CAGR of XX%.

Geographically, Middle-East is the largest market for Ophthalmology Therapeutics due to the people's high disposable income. Africa is estimated to be the fastest-growing region with a CAGR of xx% during the forecast period.

Prominent companies leading the MEA Ophthalmology Therapeutics Market are Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc., Roche Valeant, Regeneron, Santen, Bayer, Senju, Lpath, and Eye Gate Pharmaceuticals.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Indication                              

                                5.1.1 Glaucoma

                                5.1.2 Dry Eye Syndrome

                                5.1.3 Diabetic Retinopathy         

                                5.1.4 Retinal Vein Occlusion        

                                5.1.5 Age-Related Macular Degeneration (AMD)

                                5.1.6 Macular Edema    

                                5.1.7 Allergic Conjunctivitis         

                5.2 By End User               

                                5.2.1 Hospitals  

                                5.2.2 Eye Clinics

                                5.2.3 Diagnostic Centers              

                                5.2.4 Patients   

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Middle-East                                

                6.3 Africa                            

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 Allergan, Inc.                              

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Merck & Co Inc                         

                9.3 Pfizer                            

                9.4 Roche                           

                9.5 Novartis (Alcon)                       

                9.6 Valeant                        

                9.7 Regeneron                 

                9.8 Santen                         

                9.9 Bayer                            

                9.10 Senju                          

                9.11 Lpath                          

                9.12 Eye Gate Pharmaceuticals                 

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Market Outlook & Investment Opportunities                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Middle East & Africa Ophthalmology Therapeutics Market, By Region, From 2022 - 2027 (USD Billion)
  2. Middle East & Africa Ophthalmology Therapeutics Market, By Indication, From 2022 - 2027 (USD Billion)
  3. Middle East & Africa Glaucoma Market, By Region, From 2022 - 2027 (USD Billion)
  4. Middle East & Africa Dry Eye Syndrome Market, By Region, From 2022 - 2027 (USD Billion)
  5. Middle East & Africa Diabetic Retinopathy Market, By Region, From 2022 - 2027 (USD Billion)
  6. Middle East & Africa Retinal Vein Occlusion Market, By Region, From 2022 - 2027 (USD Billion)
  7. Middle East & Africa Age-Related Macular Degeneration (AMD) Market, By Region, From 2022 - 2027 (USD Billion)
  8. Middle East & Africa Macular Edema Market, By Region, From 2022 - 2027 (USD Billion)
  9. Middle East & Africa Allergic Conjunctivitis Market, By Region, From 2022 - 2027 (USD Billion)
  10. Middle East & Africa Ophthalmology Therapeutics Market, By End-User, From 2022 - 2027 (USD Billion)
  11. Middle East & Africa Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
  12. Middle East & Africa Eye Clinics Market, By Region, From 2022 - 2027 (USD Billion)
  13. Middle East & Africa Diagnostic Centers Market, By Region, From 2022 - 2027 (USD Billion)
  14. Middle East & Africa Patients Market, By Region, From 2022 - 2027 (USD Billion)
  15. Middle East Ophthalmology Therapeutics Market, By Indication, From 2022 - 2027 (USD Billion)
  16. Middle East Ophthalmology Therapeutics Market, By End-User, From 2022 - 2027 (USD Billion)
  17. Africa Ophthalmology Therapeutics Market, By Indication, From 2022 - 2027 (USD Billion)
  18. Africa Ophthalmology Therapeutics Market, By End-User, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample